Cargando…

Author correction to ‘Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication’ [Acta Pharmaceutica Sinica B 9 (2019) 769–781]

Detalles Bibliográficos
Autores principales:	Huang, Meng-Hao, Li, Hu, Xue, Rong, Li, Jianrui, Wang, Lihua, Cheng, Junjun, Wu, Zhouyi, Li, Wenjing, Chen, Jinhua, Lv, Xiaoqin, Li, Qiang, Lan, Pei, Zhao, Limin, Yang, Yongfeng, Peng, Zonggen, Jiang, Jiandong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977173/ https://www.ncbi.nlm.nih.gov/pubmed/31993316 http://dx.doi.org/10.1016/j.apsb.2020.01.002

Ejemplares similares

Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication
por: Huang, Meng-Hao, et al.
Publicado: (2019)

Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ [Acta Pharmaceutica Sinica B 12 (2022) 1567–1590]
por: Li, Guangdi, et al.
Publicado: (2023)

Erratum to “Identification of anti-Mycobacterium tuberculosis agents targeting the interaction of bacterial division proteins FtsZ and SepFe” [Acta Pharmaceutica Sinica B 13 (2023) 2056–2070]
por: Zhang, Hongjuan, et al.
Publicado: (2023)

Author correction to “Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers” [Acta Pharmaceutica Sinica B 11 (2021) 355–372]
por: Jiang, Tingting, et al.
Publicado: (2022)

Author correction to ‘Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models’ [Acta Pharmaceutica Sinica B 11(2021) 1903–1913]
por: Yu, Ziru, et al.
Publicado: (2023)

Author correction to ‘Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models’ [Acta Pharmaceutica Sinica B 11 (2021) 1903–1913]
por: Yu, Ziru, et al.
Publicado: (2023)

Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]
por: Wu, Canhao, et al.
Publicado: (2023)

Author correction to ‘Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents’ [Acta Pharmaceutica Sinica B 9 (2019) 335–350]
por: Wang, Jiabing, et al.
Publicado: (2022)

Author correction to ‘Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome’ [Acta Pharmaceutica Sinica B 9 (2019) 734–744]
por: Wang, Zhilei, et al.
Publicado: (2020)

Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ [Acta Pharmaceutica Sinica B 12 (2022) 1198–1212]
por: Wu, Yunhao, et al.
Publicado: (2022)

Author correction to “A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer’s disease” [Acta Pharmaceutica Sinica B 12, (2021) 4032–4044]
por: Lei, Ting, et al.
Publicado: (2022)

Author correction to ‘TMEM16A inhibits angiotensin II-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner’ [Acta Pharmaceutica Sinica B 11 (2021) 3994–4007]
por: Zheng, Huaqing, et al.
Publicado: (2023)

Author correction to ‘Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer’ [Acta Pharmaceutica Sinica B 2019; 9(5):1061–1077]
por: Mei, Dong, et al.
Publicado: (2020)

Author correction to ‘Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy’ [Acta Pharmaceutica Sinica B 11 (2021) 3508–3526]
por: Wang, Shuyi, et al.
Publicado: (2023)

Author correction to “YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer” [Acta Pharmaceutica Sinica B 12 (2022) 2845–2858]
por: Lai, Fangfang, et al.
Publicado: (2023)

Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B 12 (2022) 3934–3951]
por: Yang, Xuan, et al.
Publicado: (2023)

Author correction to ‘Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo’ [Acta Pharmaceutica Sinica B 11 (2021) 3950–3965]
por: Deng, Linglong, et al.
Publicado: (2023)

Author correction to “DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS‒STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis” [Acta Pharmaceutica Sinica B 12 (2022) 262–273]
por: Wang, Yuanyuan, et al.
Publicado: (2023)

Author correction to ‘Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice’ [Acta Pharmaceutica Sinica B 13 (2023) 1164–1179]
por: Fan, Xiaoqing, et al.
Publicado: (2023)

Remarks from Editor-in-Chief on the celebration of the 65th anniversary of Acta Biochimica et Biophysica Sinica
por: Ding, Jianping
Publicado: (2023)

Scientia Pharmaceutica, Autorenhinweise 2013
Publicado: (2013)

Scientia Pharmaceutica, Autorenhinweise 2015
Publicado: (2015)

Scientia Pharmaceutica, Autorenhinweise 2016
Publicado: (2016)

Acknowledgement to Reviewers of Scientia Pharmaceutica in 2017
Publicado: (2018)

Protective Effect of Bicyclol on Anti-Tuberculosis Drug Induced Liver Injury in Rats
por: Liu, Xin, et al.
Publicado: (2017)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum
por: Yao, Jianzuo, et al.
Publicado: (2022)

Effect of bicyclol on blood biomarkers of NAFLD: a systematic review and meta-analysis
por: Li, Hu, et al.
Publicado: (2020)

Effect of Bicyclol Tablets on Drug Induced Liver Injuries after Kidney Transplantation
por: Shang, Wenjun, et al.
Publicado: (2017)

The Successful Relaunch of Scientia Pharmaceutica Continues Achieving Success
por: Kubelka, Wolfgang, et al.
Publicado: (2011)

781 Multimodal Virtual Reality Encouragement
por: Thomas, Mini, et al.
Publicado: (2022)

Chemical constituents from Munronia sinica and their bioactivities
por: Li, Xiao-Li, et al.
Publicado: (2012)

A Multicenter and Randomized Controlled Trial of Bicyclol in the Treatment of Statin-Induced Liver Injury
por: Naqiong, Wu, et al.
Publicado: (2017)

On some rare weak decays of hyperons in E781
por: Landsberg, G L
Publicado: (1996)

Bicyclol Attenuates Acute Liver Injury by Activating Autophagy, Anti-Oxidative and Anti-Inflammatory Capabilities in Mice
por: Zhao, Tian-Ming, et al.
Publicado: (2020)

Bicyclol for the treatment of drug-induced liver injury: a propensity score matching analysis using a nationwide inpatient database
por: Wang, Yongfeng, et al.
Publicado: (2021)

Characterization of the complete chloroplast genome of Calophaca sinica Rehd.
por: Guo, Bin, et al.
Publicado: (2020)

Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation
por: Li, Hongxue, et al.
Publicado: (2021)

Effect of extractions from Ephedra sinica Stapf on hyperlipidemia in mice
por: FAN, YANBO, et al.
Publicado: (2015)

Characterization of Proanthocyanidin Oligomers of Ephedra sinica
por: Orejola, Joanna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ia0o0mjh4fk7si8uu820kgfeno